BusinessExosome Diagnostics Appoints Accomplished Urologist, Grannum Sant, MD, FRCS, FACS, as Head of Medical AffairsBy Nasdaq OMXMar 21, 2018, 11:41 AM UTC
BusinessExosome Diagnostics Partners with Intezyne to Develop Exosomal RNA-based Assay for Novel Cancer Resistance Pathway (CRP) InhibitorBy Nasdaq OMXMar 14, 2018, 11:30 AM UTC
BusinessExosome Diagnostics Significantly Expands Access and Coverage for its EPI Prostate Cancer Test through Agreement with FedMedBy Nasdaq OMXFeb 1, 2018, 12:35 PM UTC
BusinessExosome Diagnostics Executes Coverage Agreement for its EPI Test with Three Rivers Provider NetworkBy Nasdaq OMXDec 4, 2017, 12:33 PM UTC
BusinessExosome Diagnostics to Present a Novel Atlas of Exosomal mRNA and Long non-coding RNA Across Biofluids at American Society of Exosomes and Microvesicles Annual MeetingBy Nasdaq OMXOct 11, 2017, 11:30 AM UTC
BusinessExosome Diagnostics Launches the MedOncAlyzer™ Pan-Cancer PanelBy Nasdaq OMXAug 9, 2017, 1:02 PM UTC
BusinessExosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International ConventionBy Nasdaq OMXJun 22, 2017, 3:55 PM UTC
